Table 1. Children's characteristics in three different programs and sites in the Democratic Republic of Congo.
Children's characteristics | Amo-Congo Kinshasa | Monkole Kinshasa | HEAL Africa Goma | Total |
Total, n (%) | 147 (28.16) | 61(11.69) | 314(60.15) | 522(100.0) |
Age (years), n (%) | ||||
≤2 | 47 (31.9) | 34 (55.7) | 106 (33.8) | 187 (35.8) |
>2- more | 100 (68.1) | 27 (44.3) | 208 (66.2) | 335 (64.2) |
Sex, n (%) | ||||
Male | 76 (51.8) | 30 (49.2) | 160 (51.0) | 266 (51.0) |
Female | 71 (48.2) | 31 (50. 8) | 154 (49.0) | 256 (49.0) |
Education, n (%) | ||||
Not yet eligible | 47 (31.9) | 34 (55.8) | 252 (80.2) | 333 (63.8) |
Kindergarden | 14 (9.5) | 3 (4.9) | 4 (1.3) | 21 (4.0) |
Primary | 72 (48.9) | 18 (29.5) | 56 (17.8) | 146 (27.9) |
Secondary | 2 (1.4) | 0 (0.0) | 2 (0.7) | 4(0.7) |
Missing | 12(8.3) | 6(9.8) | 0(0.0) | 18(3.5) |
Weight-for-age z-score, n (%) | ||||
<−2 SD | 19(12.9) | 25(41.0) | 83(26.4) | 127(24.3) |
≥−2 SD | 85(57.8) | 18(29.5) | 122(38.9) | 225(43.1) |
Missing | 43(29.3) | 18(29.5) | 109(34.7) | 170(32.6) |
Height-for-age z-score, n (%) | ||||
<−2 SD | 10(6.8) | 5(8.2) | 76(24.2) | 91(17.4) |
≥−2 SD | 38(25.9) | 5(8.2) | 109(34.7) | 152(29.1) |
Missing | 99(67.3) | 51(83.6) | 129(41.1) | 279(53.5) |
Clinical stage, n (%) * | ||||
WHO I | 21 (14.3) | 5 (8.2) | 1 (0.3) | 27 (5.2) |
WHOII | 55 (37.4) | 17 (27.9) | 4 (1.3) | 76 (14.5) |
WHO III | 64 (43.5) | 36 (59.0) | 306 (97.5) | 406 (77.8) |
WHO IV | 7 (4.8) | 3 (4.9) | 3 (0.9) | 13 (2.5) |
Drug regimen, n (%) | ||||
AZT/3TC/NVP | 84 (57.1) | 49 (80.3) | 207 (65.9) | 340 (65.1) |
3TC/D4T/NVP | 36 (24.5) | 9 (14.7) | 92 (29.3) | 137 (26.2) |
Other | 27 (18.3) | 3 (4.9) | 15 (4.8) | 45 (8.7) |
CD4 cell count * (cells/µL), n (%) | ||||
0–200 | 49 (33.3) | 25 (40.9) | 120 (38.3) | 194 (37.1) |
>200–350 | 24 (16.3) | 7 (11.5) | 52 (16.5) | 83 (15.9) |
>350-more | 27 (18.5) | 7 (11.5) | 89 (28.4) | 123 (23.6) |
Missing | 47(31.9) | 22(36.1) | 53(16.8) | 122(23.4) |
Cotrimoxazole, n (%) | ||||
No | 2 (1.4) | 33 (54.1) | 12 (3.8) | 47 (9.0) |
Yes | 145 (98.6) | 28 (45.9) | 302 (96.2) | 475 (91.0) |
*At the start of antiretroviral treatment.